News from the FDA/CDC
News from the FDA/CDC
Suicide rates up significantly among adolescents, young adults
New Hampshire saw its rate more than double between 2007 and 2018.
News from the FDA/CDC
One in seven high schoolers is misusing opioids
Increased misuse among sexual minority youths warrants “tailored prevention strategies.”
News from the FDA/CDC
Antidepressant use shows gender, racial disparities
The gap between women and men is getting wider, a new analysis from the National Center for Health Statistics shows.
News from the FDA/CDC
High schoolers prefer tobacco as vapor, not smoke
“The dramatic increase in electronic vapor product use among high school students has led to increases in overall tobacco product use.”
News from the FDA/CDC
FDA expands remdesivir use for all COVID-19 hospitalized patients
An EUA of remdesivir issued in May allowed the drug to be used only for patients with severe COVID-19, specifically, COVID-19 patients with low...
News from the FDA/CDC
FDA approves point-of-care COVID-19 antigen test
“This new COVID-19 antigen test is an important addition to available tests because the results can be read in minutes, right off the testing card...
News from the FDA/CDC
FDA approves clinical trials for cannabinoid drug designed to reduce COVID-19 lung inflammation
The drug going to clinical trials, ARDS-003, would “dampen the cytokine release” and prevent development of ARDS.
News from the FDA/CDC
Use of nonopioid pain meds is on the rise
Prescription opioid use declined from 2009 to 2018, but not significantly.
News from the FDA/CDC
COVID-19: Medicare data show long hospital stays, disparities
Many beneficiaries “face structural challenges to their health,” said CMS Administrator Seema Verma.
News from the FDA/CDC
Mental health visits account for 19% of ED costs
Anxiety and fear-related diagnoses are the most costly mental and substance use disorders in emergency departments.
News from the FDA/CDC
Americans avoided emergency departments early in the pandemic
CDC: Visits over 4 weeks dropped by 42%, compared with the corresponding period in 2019.